Discovery and characterization of the tubercidin biosynthetic pathway from Streptomyces tubercidicus NBRC 13090

Microbial Cell Factories
Yan LiuWenqing Chen

Abstract

Tubercidin (TBN), an adenosine analog with potent antimycobacteria and antitumor bioactivities, highlights an intriguing structure, in which a 7-deazapurine core is linked to the ribose moiety by an N-glycosidic bond. However, the molecular logic underlying the biosynthesis of this antibiotic has remained poorly understood. Here, we report the discovery and characterization of the TBN biosynthetic pathway from Streptomyces tubercidicus NBRC 13090 via reconstitution of its production in a heterologous host. We demonstrated that TubE specifically utilizes phosphoribosylpyrophosphate and 7-carboxy-7-deazaguanine for the precise construction of the deazapurine nucleoside scaffold. Moreover, we provided biochemical evidence that TubD functions as an NADPH-dependent reductase, catalyzing irreversible reductive deamination. Finally, we verified that TubG acts as a Nudix hydrolase, preferring Co2+ for the maintenance of maximal activity, and is responsible for the tailoring hydrolysis step leading to TBN. These findings lay a foundation for the rational generation of TBN analogs through synthetic biology strategy, and also open the way for the target-directed search of TBN-related antibiotics.

References

Dec 1, 1988·The Journal of Antibiotics·K Isono
Aug 1, 1963·Chemical & Pharmaceutical Bulletin·Y MizunoS Suzaki
Oct 11, 1996·The Journal of Biological Chemistry·M J BessmanS F O'Handley
Feb 24, 2011·Microbial Biotechnology·Juan Pablo Gomez-Escribano, Mervyn J Bibb
Dec 18, 2013·Journal of Industrial Microbiology & Biotechnology·Brian O BachmannRichard H Baltz
Dec 24, 2013·Nature Chemical Biology·Daniel P DowlingCatherine L Drennan
Aug 1, 2015·Angewandte Chemie·Micah T Nelp, Vahe Bandarian
Sep 24, 2015·Chembiochem : a European Journal of Chemical Biology·Margit WinklerBirgit Wilding
Dec 9, 2015·Current Opinion in Structural Biology·Vahe Bandarian, Catherine L Drennan
Jul 30, 2017·Archives of Biochemistry and Biophysics·Stephen A MarshallDavid Leys
Nov 12, 2017·Current Opinion in Chemical Biology·Margit Winkler

❮ Previous
Next ❯

Datasets Mentioned

BETA
MG706975

Methods Mentioned

BETA
amidation
nuclear magnetic resonance
NMR
deamination
targeted modification
PCR

Software Mentioned

Glimmer
FramePlot

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Biomaterial Engineering

Advances in biomaterial engineering have permitted the development of sophisticated drug-releasing materials with a biomimetic 3D support that allow a better control of the microenvironment of transplanted cells. Here is the latest research.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.